A finalized phase II report of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).

被引：0
|
作者：
Simon, G. R.
Janne, P. A.
Langer, C.
Clarie, V.
Dowlati, A.
Gadgeel, S. M.
Kelly, K.
Ye, Z.
Obasaju, C. K.
Hood, K. E.
Kindler, H. L.
机构：
[1] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
[2] Dana Farber Canc Inst, Boston, MA 02115 USA
[3] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[4] Univ New Mexico, Canc Res & Canc, Albuquerque, NM 87131 USA
[5] Case Western Reserve Univ, Cleveland, OH 44106 USA
[6] Wayne State Univ, Detroit, MI 48202 USA
[7] Univ Colorado, Hlth Sci Ctr, Aurora, CO USA
[8] Eli Lilly & Co, Indianapolis, IN 46285 USA
[9] Univ Chicago, Chicago, IL 60637 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2006年 / 24卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：91S / 91S
页数：1
相关论文
共 50 条
  • [1] A phase 2 clinical trial of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with peritoneal mesothelioma (PM).
    Simon, GR
    Janne, PA
    Langer, CJ
    Verschraegen, CF
    Dowlati, A
    Gadgeel, SM
    Kelly, K
    Taylor, L
    Obasaju, CK
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 679S - 679S
  • [2] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
    Janne, PA
    Simon, GR
    Langer, CJ
    Taub, RN
    Dowlati, A
    Fidias, P
    Bloss, LP
    Ye, Z
    Obasaju, C
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 637S - 637S
  • [3] An update of pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (pts) with malignant pleural mesothelioma (MPM): A phase II clinical trial
    Janne, P
    Simon, G
    Langer, C
    Taub, R
    Dowlati, A
    Fidias, P
    Bloss, L
    Ye, Z
    Obasaju, C
    Kindler, H
    LUNG CANCER, 2005, 49 : S282 - S282
  • [4] Pemetrexed plus gemcitabine as first-line chemotherapy for patients with peritoneal mesothelioma:: Final report of a phase II trial
    Simon, George R.
    Verschraegen, Claire F.
    Jaenne, Pasi A.
    Langer, Corey J.
    Dowlati, Afshin
    Gadgeel, Shirish M.
    Kelly, Karen
    Kalemkerian, Gregory P.
    Traynor, Anne M.
    Peng, Guangbin
    Gill, John
    Obasaju, Coleman K.
    Kindler, Hedy L.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (21) : 3567 - 3572
  • [5] A phase 2 clinical trial of pemetrexed plus gemcitabine as front-line chemotherapy for patients with malignant pleural mesothelioma (MPM).
    Janne, PA
    Obasaju, C
    Simon, G
    Taub, R
    Kelly, K
    Fidias, P
    Bloss, LP
    Kindler, HL
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 629S - 629S
  • [6] A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)
    Parra, HS
    Zucali, R
    Favaretto, A
    Grossi, F
    Fusi, A
    Marangolo, M
    Del Conte, G
    Ceribelli, A
    Bearz, A
    Ceresoli, G
    LUNG CANCER, 2005, 49 : S229 - S229
  • [7] A phase II study of pemetrexed and carboplatin as front-line chemotherapy in patients with malignant pleural mesothelioma (MPM)
    Zucali, P. A.
    Ceresoli, G. L.
    Favaretto, A. G.
    Cortinovis, D.
    Grossi, F.
    Marangolo, M.
    Del Conte, G.
    Ceribelli, A.
    Bearz, A.
    Parra, H. Soto
    Santoro, A.
    ANNALS OF ONCOLOGY, 2005, 16 : 28 - 28
  • [8] Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.
    McCleod, M
    Treat, J
    Christiansen, NP
    Mintzer, DM
    Bonomi, P
    Bloss, LP
    Taylor, L
    Monberg, MJ
    Ye, Z
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 650S - 650S
  • [9] Docetaxel plus gemcitabine as front-line chemotherapy in elderly patients with lung adenocarcinomas: A multicenter phase II study
    Boukovinas, I.
    Souglakos, J.
    Hatzidaki, D.
    Kakolyris, S.
    Ziras, N.
    Vamvakas, L.
    Polyzos, A.
    Geroyianni, A.
    Agelidou, A.
    Agelaki, S.
    Kalbakis, K.
    Kotsakis, A.
    Mavroudis, D.
    Georgoulias, V.
    LUNG CANCER, 2009, 63 (01) : 77 - 82
  • [10] Pemetrexed (P) plus gemcitabine (G) as front-line chemotherapy for patients (Pts) with locally advanced or metastatic non-small cell lung cancer (NSCLC): A phase II clinical trial.
    West, H
    Belt, RJ
    Wakelee, HA
    Bloss, LP
    Taylor, L
    Monberg, MJ
    Ye, Z
    Obasaju, CK
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 649S - 649S
12345